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Abstract  
Traumatic brain injury (TBI) is the brain injury that occurs whenever a physical force that impacts the head leads to 
neuropathology. The types of primary TBI are penentrating TBI or non-penetrating TBI and it can lead to 
intracerebral contusions, hemorrhages or extra-axial hematomas. Patients with TBI can also have skull fractures or 
concussions. The injury severity can be classified in many ways but the most established and common used is the 
Glascow Coma Scale (GCS). However, with the GCS, each of the severity criteria has limitations and might mot be 
an accurate predictor of TBI severity and outcome when used alone. For this reason it is often used in conjunction 
with other parameters (Abbreviated Injury Scale - AIS).  
Secondary Brain Damage is the injury that occurs to the TBI patient not at the time of the accident, but during the 
following minutes, hours or days. There are many mechanisms that lead to development of cerebral edema, blood-
brain barrier disruption, vasospasm, increase in volume of bleeding, contusions and intracranial hypertension. 
These mechanisms can act either in cellular level or systemic level. The cellular mechanisms that lead to secondary 
brain damage include necrosis or apoptosis, mitochondrial dysfunction, excitotoxicicty, formation of free radicals, 
changes in cerebral glucose metabolism and inflammation. The mechanisms at systemic level include hypoxia-
cerebral oxygenation, hypo or hypertension, hypo or hyper-capnia, anemia, hyponatremia and hyper or 
hypoglycemia. 
The first tool to diagnose severe TBI and secondary brain injury is neurological assessment. Neuroimaging is one of 
the most important ways for diagnosis. Computed Tomography (CT scan), Magnetic Resonance Imaging (MRI), 
cerebral angiography, transcranial Doppler, CT perfusion, Xenon CT, MRI diffusion, MRI perfusion, MRI 
spectrometry and Positron Emission Tomography (PET) are possible ways of imaging that not only help in the 
diagnosis but give important information that help in choosing the correct management. Moreover, 
neuromonitoring, helps in the correct management of the patient.  
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INTRODUCTION  
Brain injury is called any damage to the brain that 
can affect a person physically, emotionally or 
behaviorally. Depending on the cause, brain injuries 
can be categorized into traumatic or non-traumatic 
brain injuries. Non-traumatic injuries are those that 
do not occur as a result of an external force or a 
trauma. The main cause is usually a stroke, which is 
the interruption of blood supply to a section of the 
brain. Depending on the part of the brain affected 
and the extent of blood shortage, the consequences 
of a stroke vary widely. A stroke in the left 
hemisphere may result in a degree of paralysis or 
loss of feeling on the right side, reduction in the right 
field of vision, loss of speech and comprehension. A 
stroke in the right hemisphere may result in a degree 
of paralysis or loss of feeling on the left side, 
difficulty in expressing emotions and impulsive 
actions. Other causing factors are illnesses such as 
cancer or tumors and infectious diseases such as 
brain infections or inflammation. In addition, lack of 
oxygen or toxicity is also factors responsible for non-
traumatic injury.1-6   
Traumatic brain injuries (TBI) occur when physical 
external forces impact the brain either from a 
penetrating object, or a bump, blow or jolt to the 
head. Traumatic brain injuries can vary from mild to 
severe depending on the type of injury and can be 
divided into two categories: a) penetrating or open 
TBI where the skull is pierced by an object such as a 
knife or a bullet and b) non-penetrating (or blunt TBI 
or closed head injury) where the injury is caused by 
an external force which results in the movement of 
the brain within the skull. Usual causes of non-
penetrating TBIs are falls, motor vehicle crashes, 
sport injuries or being struck by an object.1-6    
Traumatic brain injury is one of the most common 
causes of mortality and disability from trauma 
worldwide, especially in children and young adults, 
under 45 years old. TBI is found to be more frequent 
than other common diseases including breast 
cancer, AIDS, Parkinson’s disease and multiple 
sclerosis. Male people between 14 and 24 years old 
constitute the most commonly affected group from 
TBI. Females, children and older people also may be 
at risk for TBI, though female patients not only 
sustain TBI less frequently, but when they are 
affected they seem to have better outcome 
compared to that of males. Though the great 
advance in emergency and intensive care medicine 
has ameliorated the mortality rate related to TBI, 
still many deaths are attributed to trauma. In 
addition, people that survive the injury most 
probably they will suffer from neurological and 
neuropsychological problems. The most common 
causes of TBI are falls and occur most frequently to 
young children and older people. The next two more 
common causes of TBI are unintentional blunt 
trauma, followed closely by motor vehicle accidents. 
Unintentional blunt trauma is an accident that 
involves being struck by or against an object such as 
sport-related injuries. Bicycling, football, playground 
activities, basketball and soccer result in the most 
TBI related emergency room visits. Finally TBIs can 
be caused by a blast trauma from roadside bombs 
and since 2014 has become a common cause of 
injury.1-6   
In the United States (USA), the number of deaths 
from TBI is greater than 50.000 per year and 
constitutes 33% of all civilian trauma-related deaths. 
It is estimated that in US every 15 seconds a TBI 
occurs and as a consequence 1.7 million head 
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injuries per year are generated. The main causes of 
TBI are falls, motor vehicle accidents and assaults 
and the majority of patients are male young adults. 
As these young people are probable to suffer from 
trauma-related disability, extended rehabilitation 
and reintegration is required. It is reported that 
approximately 80000 are left with permanent 
disability.  
In Europe, according to a systematic review of brain 
injury epidemiology published in 2006, 150-200 
hospital admissions with TBI per 100000 of the 
population were reported. These patients represent 
the 0.015 – 0.02% of total population.  The age 
group of 15 – 35 years old is the one of higher risk 
especially for males, as the ratio of males/females is 
found to be 2.5:1. The death rate from TBI in Europe 
is 14 – 30 per 100.000 of the population. Those data 
are derived from national studies realised in 
Denmark, Sweden, Finland, Portugal, Germany, and 
from local studies realised in regions within Norway, 
Sweden, Italy, Switzerland, Spain, Denmark, Ireland, 
the U.K. and France.  
In Greece the incidence of patients with severe TBI is 
estimated to 10.000 per year. According to the 
Hellenic Society of Trauma and Emergency Surgery, 
more than 50% of patients with TBI were due to 
traffic accidents and approximately 30% were due to 
falls. The ratio of male patients/female patients was 
approximately 2.5:1. Most people with TBI are of age 
between 15 - 44 years old, though TBIs were found 
to be more lethal in the age group of 45-64 years 
old. 5, 7-12   
 
DIAGNOSIS OF SECONDARY BRAIN DAMAGE  
TBI occurs in two phases: primary and secondary TBI. 
The primary injury, as analyzed in the first part, is 
the result of the direct physical impact to the brain 
parenchyma, which leads as a consequence to 
structural and shearing injury of neurons, injury to 
vessels and interruption of neurochemical processes. 
All these, result in hemorrhage, edema and 
compression of intracranial structures. A cascade of 
events starts within minutes of the primary injury 
and these pathophysiologic processes may last from 
hours to days. The result is further neuronal injury, 
termed as secondary brain damage. While primary 
injury cannot be altered after the time of trauma, 
secondary damage sometimes can be prevented.  
The causes of secondary brain damage can be 
categorized into those that occur on cellular level 
and those that occur on the systemic or 
extracerebral level. Factors that contribute to 
secondary brain damage on systemic level are 
mainly ischemic in nature and include hypoxia, 
hypotension, hypercapnia, acidosis and 
hyperglycemia. The mechanisms of secondary TBI on 
the cellular level include: necrosis - apoptosis, 
mitochondrial dysfunction, excitotoxicity, disruption 
in ATP metabolism, and disruption in calcium 
homeostasis, increase in inflammatory mediators 
and cells, free radical formation, DNA damage, brain 
glucose utilization disruption, microcirculatory 
dysfunction and microvascular thrombosis. The 
mechanisms of secondary brain injury will be further 
analyzed in the next paragraph. All these factors lead 
to development of cerebral edema, blood-brain 
barrier disruption, vasospasm, increase in volume of 
bleeding and contusions, and intracranial 
hypertension.17-18, 20-21  
 
NEUROLOGICAL ASSESSMENT 
The primary tool for clinically evaluating a patient 
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with TBI is the neurological examination. Examining 
the patient with TBI in a detailed way and 
understanding the extent of neurologic impairment 
is absolutely necessary. Minimum documented 
neurological observation should be: GCS scale, pupil 
size and reactivity, limb movements, respiratory 
rate, heart rate, blood pressure and temperature. 
Beside GCS, a new scoring system has been 
developed in 2005, called the “Full Outline of 
UnResponsiveness” (FOUR). The FOUR scale is 
superior to GCS as it provides further information 
like brainstem reflexes, visual tracking, breathing 
patterns and respiratory drive. It has also the 
advantage that critically ill intubated patients can be 
evaluated, as it does not depend on verbal response. 
In addition it can differentiate between a locked-in 
state and a vegetative state, via the addition of 
testing eye tracking, thus incorporating midbrain and 
pontine functions. Another advantage of the FOUR 
scoring is that it gives all components equal weight, 
while the GCS scale is weighted towards motor 
responses. There are five scores for each type of 
response. For eye response the scores are: E4 for 
eyelids open or opened, tracking or blinking to 
command, E3 for eyelids open but not tracking, E2 
for eyelids closed but open to loud voice, E1 for 
eyelids open but closed to pain and E0 for eyelids 
remaining closed with pain. For motor response the 
scores are: M4 for thumbs up, fist or peace sign, M3 
for localizing to pain, M2 for flexion response to 
pain, M1 for extension response to pain and M0 for 
no response to pain or generalized myoclonus 
status. For brainstem reflexes the scores are: B4 for 
pupil and corneal reflexes present, B3 for one pupil 
wide fixed, B2 for pupil or corneal reflexes absent, 
B1 for pupil and corneal reflexes absent and B0 for 
absent pupil, corneal and cough reflex. For 
respiration pattern the scores are: R4 when the 
patient is not intubated, and he is with a regular 
breathing pattern, R3 when the patient is not 
intubated but he has a Cheyne-Stokes breathing 
pattern, R2 when he is not intubated and he has an 
irregular breathing, R1 when the patient breathes 
above ventilatory rate and R0 when he breathes at 
ventilator rate or apnea.11, 19, 20, 26 
NEUROIMAGING 
Neuroimaging provides supportive information and 
there are many techniques that can be used: 
The primary neuroimaging modality used for 
patients with TBI is Computed Tomography (CT). 
When performed without the use of contrast it takes 
only a few minutes to be performed and can provide 
useful data. The main indications for CT are: GCS 
score less than 15, loss of consciousness for longer 
than 5 minutes or antegrade amnesia, clinical 
evidence of basilar skull fracture, depressed skull 
fracture on clinical examination, penetrating injury, 
anisocoria or fixed and dilated pupils, any 
neurological deficit, known bleeding diathesis and 
anticoagulant treatment. In addition CT can be 
performed when there are symptoms for high risk 
such as focal neurological deficits, penetrating head 
wound, palpable depressed skull fracture, and 
impaired mental status that is not caused by drugs 
or other intoxicants. CT scan images can show 
fractures, hemorrhages, hematomas, hydrocephalus, 
contusions and brain tissue swelling. It generally 
provides sufficient information for appropriate 
surgical management.  
Magnetic Resonance Imaging (MRI) is another 
imaging modality that can be used in patients with 
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TBI. MRI can provide greater structural detail than 
CT, it is a more sensitive test and can show subtle 
changes in the brain that the CT might have missed. 
Though MRI does not affect acute clinical care, it is 
useful for prognostication, particularly as brainstem 
lesions and diffuse axonal injury that are not easily 
seen in CT can be easily identified in MRI. MRI is 
superior to CT when it delineates corpus callosal 
pathology in white matter diffuse axonal shearing 
injury. However, MRI has some disadvantages as in 
penetrating TBI there is a great risk of heat and 
movement of retained foreign bodies by the MRI’s 
high magnetic field. Also when the patient is 
clinically unstable MRI cannot be performed because 
clinical monitoring during the study is difficult. 
Finally, MRI is quite more expensive and time-
consuming in the emergency department setting. 
Other imaging modalities include cerebral digital 
subtraction angiography (DSA), which is 
recommended when a cerebrovascular injury is 
suspected and transcranial Doppler when 
vasospasm or other cerebral blood flow issues are of 
concern. Transcranial Doppler is a bedside non-
invasive technique that can provide useful real time 
physiological data, as it can diagnose vasospasm, 
which is a secondary injury with high incidence 
among patients with TBI. The incidence of 
vasospasm in patients with blast-related penetrating 
TBI reaches 50%. Thus, it is recommended that 
patients, especially those with acute penetrating TBI 
from explosives, should undergo regular Doppler 
assessment and if moderate or severe vasospasm is 
found then cerebral angiography can be performed 
as it might be more invasive but it will offer a 
definite diagnosis and endovascular intervention. 
While conventional angiography is the gold-standard 
technique for these cases, CT angiography is widely 
available in facilities and offers some more 
advantages. Its sensitivity in diagnosing vascular 
injury is higher even than that of MRI angiography.  
The last years, more neuroimaging modalities have 
been introduced for the diagnosis of brain injury. 
These include CT perfusion, Xenon CT, MRI diffusion, 
MRI perfusion, MRI spectrometry, Positron Emission 
Tomography (PET). CT perfusion is a modified angio-
CT and with the use of a non-diffusible tracer, 
cerebral blood volume and regional cerebral blood 
flow (CBF) can be measured (quantitative) at high 
resolution. Xenon CT is another method that helps in 
measuring quantitatively regional CBF, using Xenon 
as a contrast diffusible agent. This method has many 
advantages: it provides reliable results with high 
spatial accuracy, it allows the combination of 
regional CBF with CT imaging and it is a technique 
that can be applied at bedside with the introduction 
of portable CT scanner. MRI diffusion is a technique 
that quantifies with a ratio the typology of regional 
brain edema either this is cytotoxic or vasogenic. 
With MRI perfusion a non-quantitative mapping of 
regional perfusion can be produced and allows a 
description of penumbra, the area in which reduced 
perfusion is mismatched from the cytotoxic 
edematous area. MRI spectrometry is a technique 
that produces semi-quantitative mapping of cerebral 
metabolites suggesting areas of ischemia and 
excitotoxicity. Finally, PET is an imaging technique 
that offers a quantitative measurement of regional 
cerebral metabolic rate for glucose. When combined 
with CT, the technique is then called PET-CT and it 
offers information about the metabolic rate for 
glucose in combination with traditional CT 
imaging.2,11,16-17,26  
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CEREBROSPINAL FLUID ANALYSIS 
Cerebrospinal fluid (CSF) is a dynamic metabolic 
active substance, which can give valuable 
information in many occasions such as inflammatory 
conditions or subarachnoid hemorrhage. As a result 
it can occasionally be useful in TBI. It is obtained by a 
procedure called lumbar puncture. As it is in direct 
contact with the extracellular matrix in the brain, its 
composition reflects biochemical changes in this 
organ, therefore its analysis can show alterations 
that can help in the diagnosis of TBI. There are 
several biomarkers that can be used in order to 
indicate BBB integrity, neuroinflammation, as well as 
axonal, neuronal and astroglial damage. It is 
important to mention that there are many studies 
and there is a lot of research in order to find 
biomarkers that will help in diagnosing secondary 
brain injury and will help in the patient’s prognosis.  
The BBB as it has been already mentioned has an 
important role in maintaining a regulated 
microenvironment for reliable neuronal signaling. 
The CSF serum albumin ratio is a common biomarker 
of BBB function. Albumin is synthesized in the liver 
and consequently most of albumin in CSF is derived 
from the blood via passage across the BBB. An 
increase in this ratio indicates BBB disruption, which 
is found in patients with severe TBI associated with a 
neuroinflammatory response. 
After severe TBI, there is an acute inflammatory 
response within the CNS. This response is reflected 
in the concentration of various CSF components such 
as inflammatory proteins. Levels of inflammatory 
proteins such as IL-6, IL-8 and IL-10 are increased in 
the CSF in cases of severe TBI. The magnitude of the 
rise correlates with the patient’s outcome and in 
some cases also with the extent of BBB dysfunction, 
as shown by the CSF: serum albumin ratio. 
Acute axonal injury in severe TBI can be identified by 
a high concentration of tau protein, a protein highly 
expressed in thin, nonmyelinated axons of cortical 
interneurons. Total tau protein levels in ventricular 
CSF correlate with lesion size and clinical outcome in 
patients with TBI. Also, neurofilament light 
polypeptide helps in the diagnosis of axonal injury. 
Neurofilaments are composed of neuron-specific 
intermediate filaments. Each intermediate filament 
consists of one light subunit plus either a medium 
subunit or a heavy subunit arranged head-to-tail. 
High levels of phosphorylated heavy subunits have 
been demonstrated in the ventricular CSF of patients 
with severe TBI. 
Finally, γ-Enolase is a glycotic enzyme enriched in 
neuronal cell bodies. Its level in CSF can identify 
severe TBI as it strongly correlates with mortality. 
More specifically its concentration is higher in non-
surviving patients than in survivors. Its prognostic 
value can be combined with other TBI severity scores 
such as GCS score [31, 32]. 
 
NEUROMONITORING IN SECONDARY BRAIN 
DAMAGE 
Patients with severe TBI and secondary brain injury 
are nursed in ICU and require special attention, care 
and management. Neuromonitoring refers to the 
continuous monitoring of the brain function with the 
use of digital technology. It helps in the recording of 
many parameters in a constant way; these 
parameters are brain and body temperature, intra-
cranial pressure, blood pressure and oxygenation, 
pH, brain metabolic and electrophysiological 
situation, cerebral perfusion and other parameters. 
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 21/02/2020 06:38:40 |
ΤΟΜΟΣ 4, ΤΕΥΧΟΣ 2 (ΑΠΡΙΛΙΟΣ – ΙΟΥΝΙΟΣ 2018)                                                                HEALTH AND RESEARCH JOURNAL HRJ 
 
 
 
 
Σελίδα 66 
 
 
Therefore, essential monitoring includes 
electrocardiography (ECG), arterial oxygen 
saturation (SpO2); capnography (end-tidal CO2, 
PetCO2), arterial blood pressure (arterial catheter), 
central venous pressure (CVP), systemic 
temperature, and urine output, arterial blood gases 
and serum electrolytes and osmolality. Invasive 
arterial pressure allows beat-to-beat monitoring of 
ABP and regular assessment of arterial blood gases 
and glucose.  
The advantage that neuromonitoring offers is that 
secondary brain injury becomes perceptual in early 
stages, before the patient deterioration, and 
therefore there is the opportunity to prevent them 
with the appropriate treatment either this is surgical 
or conservative.28,30,33 
 
INTRACRANIAL PRESSURE  
Intracranial pressure (ICP) is the cerebrospinal fluid 
pressure. ICP monitoring offers continuous display of 
ICP, accurate calculation of cerebral perfusion and 
assessment of intracranial compliance. ICP is 
measured with the use of a catheter implanted 
either inside the brain parenchyma or inside the 
ventricular system. In the case of the intraventricular 
position the catheter’s tip is positioned at the level 
of Foramen of Monro without loss of fluid from the 
system. ICP can be recorded at various sites in the 
cranial vault. For example it can be recorded in the 
subdural, the subarachnoid or the epidural space, 
though the recordings of ICP in the subdural and 
epidural space underestimate true ICP levels. 
Under normal conditions cardiac and respiratory 
pulse are superimposed on the baseline level of ICP, 
resulting in a characteristic waveform. It is important 
to mention that ICP values are dependent on the 
intrathoracic pressure, which influences venous 
outflow from the intracranial space. In cases where 
ICP increases, there are obvious certain pathological 
waveforms on the ICP record: there are termed as 
Lundberg A (plateau waves, ICP>50 mmHg), B 
(pressure pulses, ICP > 20 mmHg to 50 mmHg) and C 
waves (figure), defined by their peak pressures and 
duration. Not rarely, though there are changes in 
ICP, that cannot be easily classified as one of these 
patterns. 
Generally, it is suggested that all patients with 
severe TBI (GCS<9) and an abnormal CT scan, should 
be followed with ICP monitoring. ICP monitoring is 
also recommended in patients with severe TBI and a 
normal CT scan if two or more of the following 
features are noted at admission: age over 40 years, 
unilateral or bilateral motor posturing or systolic 
blood pressure < 90mm Hg. The reason is that these 
patients are of similar risk for an increase in ICP with 
those with an abnormal CT scan. However, it is not 
considered necessary in patients who are considered 
to be unsalvageable or in older patients and in 
general patients that are not expected to develop 
intracranial hypertension. Usually each center has 
developed its own protocol according to which it is 
decided whether the patient will be ICP monitored. 
Exclusion criteria often include patients with 
bilateral unreactive midriasis, with untreatable 
lesions or extracranial lesions difficult to manage, 
patients with high GCS motor score (5) or patients 
of advanced age. Patients with a potentially evolving 
lesion or a diffuse lesion at risk of high ICP should be 
ICP monitored even if they have a less severe initial 
neurological score.  
There is more than one method that ICP can be 
measured and each method measures in different 
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anatomical sites. The most common anatomical sites 
are the epidural and intraventricular spaces and the 
parenchyma. The methods include fluid-coupled 
systems with an external transducer and fibre optic 
and piezo-resistive systems. The ventricular method 
is a reliable method with low cost. It is most 
accurate, its recalibration is possible and it gives the 
opportunity to withdraw CSF in order to lower ICP. 
The fact that it allows fluid release in order to treat 
ICP elevation is really important and this is the 
reason that it constitutes the most preferred 
method. Its greater disadvantage is that there is a 
high risk of infection and hemorrhage. The 
parenchymal method is also reliable and it has the 
advantage of simple catheter insertion. In this 
method recalibration is not possible and there is also 
a small risk of hemorrhage. In addition it is an 
expensive method. The epidural method is simple 
with low infection rate, though it is expensive and 
there is the risk of artifacts. Its recalibration is not 
always possible. In general, the preferred site for ICP 
monitoring device is the right frontal lobe, which the 
non-dominant hemisphere and eloquent brain tissue 
can be minimized. However, this may or may not be 
the tissue involved in the head injury, and 
interpretation of pressure readings may be difficult if 
the monitor is sited in the middle of an expanding 
contusion. There are suggestions that the 
combination of ICP and MABP is more important 
than ICP alone. Thus Cerebral Perfusion Pressure 
(CPP) may be a more appropriate measure and 
target than ICP, where CPP is defined as the 
difference between mean arterial pressure and 
mean ICP [CPP= MABP-ICP]. The normal value of ICP 
is 15mmHg. Though conventionally the threshold of 
ICP value for treatment is 20 mmHg, it is 
recommended that after a few days the threshold be 
elevated to 25mm Hg. The threshold for CPP 
treatment is not stable but depends on the type of 
CT, the age and previous arterial hypertension. For 
example older patients might need a CPP within 70-
90mm Hg, while children and young adult patients 
should have a CPP target not below 50mm Hg. 
Intracranial hypertension leads to a reduced cerebral 
perfusion and as a consequence to cerebral 
ischemia. The primary goal of an adequate CPP is to 
maintain CBF and tissue oxygenation. ICP can be 
controlled by a variety of methods such as 
hyperventilation, hyperosmolar therapy, 
hypothermia, the use of barbiturates and finally with 
neurosurgical interventions.17,20,30,34-37 
Hyperventilation: A reduction in PaCO2 causes 
cerebral vasoconstriction, leading to a reduction 
cerebral blood volume (CBV) and ICP. However, 
hyperventilation has been shown to exacerbate 
cerebral hypoperfusion and may result in ischemia. 
Moderate hyperventilation to a PaCO2 value of 4 –
4.5kPa is reserved for those with intractable 
intracranial hypertension and should be guided by 
monitoring such as jugular venous oxygen saturation 
to ensure adequate cerebral oxygenation. 
Hyperosmolar therapy: This type of therapy is really 
useful in patients with an acute increase in ICP. The 
most commonly used agent in this therapy is 
mannitol, given in intermittent boluses rather than 
continuous infusions as this way it seems to be more 
effective. However, special attention needs to be 
taken in order to prevent serum osmolarity 
increasing as this might lead to neurological 
complications, renal complications and other 
complications including hypotension, intravascular 
volume depletion, hyperkalemia and rebound 
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intracranial hypertension. Lately, the use of 
hypertonic saline is increasing as it has fewer side-
effects and may control ICP refractory to mannitol. 
Hypothermia: Moderate hypothermia effectively 
reduces ICP and is often included in management 
algorithms. However, studies have failed to prove an 
association with consistent and statistically 
significant reduction in mortality.  
Barbiratures:  Barbiturates has proved to lower ICP 
but there is little evidence that they improve the 
patient’s outcome. As they are associated with 
significant cardiovascular instability they are 
reserved only for refractory intracranial 
hypertension. Dosage is titrated to produce burst 
suppression with electroencephalography (EEG). 
Neurosurgical interventions: The main effective 
intervention is drainage of CBF via an external 
ventricular drain. More specifically, this method can 
be applied when the “ventricular” method of 
measuring ICP has been used. When intracranial 
hypertension cannot be cured with medical therapy 
then a decompressive craniectomy is a useful 
method. In this procedure a section of skull vault is 
removed, allowing the brain to expand and the ICP 
to decrease. However, there is little consensus on its 
use, and studies have shown that the outcome for 
these patients is worse than those who are treated 
with medical therapy. For this reason, 
decompressive craniectomy is currently reserved for 
when other methods of ICP control have failed.30 
  
ELECTROPHYSIOLOGICAL MONITORING  
In patients with severe TBI it is important to 
comprehensively monitor cerebral metabolic and 
functional endpoints in order to allow the physician 
to determine the physiological, functional and 
metabolic status of the brain and to choose the 
correct targeted therapy for each patient. 
Electroencephalogram (EEG) is a useful tool in 
clinical neuromonitoring of severe TBI. It can 
monitor the depth of coma, detect non-convulsive 
seizures or seizures activity in pharmacologically 
paralyzed patients and it can diagnose brain death. It 
can also detect non-convulsive status epilepticus, 
motor evoked potentials (MEP), somatosensensory 
evoked potentials (SSEP) and brainstem auditory 
evoked response (BAER). There are suggestions for a 
continuous EEG in patients with TBI in order to 
diagnose post-traumatic seizures. Usually, patients 
with severe brain injury have 24-hour EEG 
monitoring, while MEP, SSEP, and BAER may be 
evaluated at regular intervals. Sensory-evoked 
potentials can yield data on current brain function in 
very severe TBI patients. However, their use is very 
limited in the initial management of TBI.28,34 
 
JUGULAR VENOUS SATURATION MONITORING  
Jugular saturation monitoring (SjO2) is a newer 
method adjunct to ICP that allows the clinician to 
monitor cerebral oxygen extraction for any given 
CPP and it can demonstrate cerebral hypoxia. Up to 
now, continuous SJO2 monitoring is not necessary, as 
it has not been shown to be of benefit. However, 
episodic SJO2 monitoring can sometimes detect 
episodes of cerebral ischemia and increased oxygen 
extraction allowing this way the optimization of 
hyperventilation in the treatment of intracranial 
hypertension. In addition, a decline of SJO2 can be a 
sign of a very critical CPP and low levels of SJO2 can 
also be associated with critical levels of anemia. SJO2 
is not frequently used as it is considered to be a 
more confirmative monitoring than an informative 
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one. Also, SJO2 after the early few days reflects more 
the decline of cerebral metabolic rate for oxygen 
(CMRO2) than the appropriateness of CBF. Values of 
SJO2 that are stable high indicate post-traumatic 
CMRO2 depression or the result of therapies that 
induce a decline of neuronal activities such as deep 
sedation, hypothermia or the use of barbiturates. 
Another similar well-documented technique is brain 
tissue oxygen monitoring (PbrO2 or PtiO2), which is 
more frequently used since the late 1990’s. The 
probe is a fine parenchymal device into a selected 
area of the brain parenchymal and connected to a 
digital monitor.17 
 
BRAIN TISSUE OXYGEN LEVELS – THERMAL 
DIFFUSION REGIONAL CEREBRAL BLOOD FLOW 
Both, brain tissue oxygen levels (PtiO2) and thermal 
diffusion cerebral blood flow (TD-rCBF) 
measurements constitute an alternative to SJO2. 
Though these monitoring devices are extremely 
focal, when placed in apparently normal brain they 
are sensitive to the same variables that affect SJO2, 
which is a recognized global monitoring modality. 
The main advantage of TD-rCBF over PtiO2 is that it is 
not affected by multiple factors, while PtiO2 is a 
proxy of rCBF, arterial oxygenation, and regional 
cerebral metabolic rate for oxygen (rCMRO2). 
Though the regionality of these methods is a great 
limitation, it is also the main reason that they can be 
placed in perilesional edematous regions, as there 
they can easily document the way that the 
penumbra is sensitive to changes of physiological 
variables. Unfortunately, in clinical practice the 
placing of the sensor in the edematous area has 
success only in 50% of patients.20 
 
MICRODIALYSIS 
Cerebral microdialysis is a recently developed 
invasive laboratory device, bedside monitor to 
analyze brain tissue biochemistry. It is a technically 
feasible method that helps in monitoring 
biochemical disturbances in the brain. Usually, a 
catheter is inserted in “susceptible” brain tissue to 
measure biochemical changes in the area of brain 
most vulnerable to secondary insults. A second 
catheter is placed in apparently normal tissue for 
comparison. Different assays are available to 
measure dialysate concentrations including glucose, 
lactate, pyruvate, glycerol, and glutamate. Although 
it cannot measure the rate of molecular production 
or consumption, it gives the opportunity of detecting 
at the bedside conditions of metabolic crisis with 
lactate production in excess of pyruvate, abnormal 
cell firing and cytotoxic damage associated with 
glutamate elevation, and excessive consumption or 
defect in the metabolism of glucose. Cerebral 
hypoxia or ischemia has found to result in a 
significant increase in the lactate : pyruvate ratio 
(LPR). The threshold for LPR > 20-25 is considered a 
threshold for cerebral ischemia is considered 20-25 
and is associated with poor outcome in TBI. 
Although, microdialysis is a well-established tool that 
provides additional assistance in the management of 
patients with severe TBI, its use is very limited.17,28   
 
TRANSCRANIAL DOPPLER ULTRASONOGRAPHY 
Transcranial Doppler (TCD) is a non-invasive method 
used to measure CBF velocity and estimate 
autoregulation. Its use is continuously increasing in 
the neuromonitoring of TBI. It can diagnose 
complications such as vasospasm, critical elevations 
of ICP and decreases in CPP, carotid dissection, and 
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cerebral circulatory arrest (brain death). It is 
important that it can predict post-traumatic 
vasospasm before its clinical manifestation. TCD is 
suggested a non-invasive alternative technique for 
assessment ICP and CPP. It has a high overall 
sensitivity for confirming brain death (75-88%) and a 
high overall specificity (98%). However, it has the 
disadvantage that it is operator dependent and 
relatively unstable and for this reason though it is an 
established monitoring modality in neurocritical 
care, it is routinely applied only in a few centers.17,28  
 
NEAR INFRARED SPECTROSCOPY 
Near infrared spectroscopy is a monitor of cerebral 
oxygenation and CBV. It has the advantage that it is 
a continuous, direct and a non-invasive tool. In 
cerebral tissue, there are two main light–absorbing 
compounds, called chromophores, hemoglobin (Hb) 
and cytochrome oxidase. This method is based on 
the fact that these chromophores have differential 
absorption properties in the NIR range. More 
specifically at 760 nm, Hb occurs primarily in the 
deoxygenated state (deoxyHb), whereas at 850 nm, 
it occurs in the oxygenated state (oxyHb). Hence, by 
monitoring the difference in absorbency between 
these two wavelengths, the degree of tissue 
deoxygenation can be evaluated. Compared to SjO2, 
NIRS is a less accurate method in determining 
cerebral oxygenation. Although, NIRS is an evolving 
technology and a potential as a clinical tool for 
bedside cerebral oxygenation and CBF 
measurements, its use in neurocritical care remains 
very limited due to limited availability and high cost 
of these devices.4,28 
 
BRAIN TEMPERATURE 
In literature, it is observed that after head injury, the 
brain temperature compared with body temperature 
is up to 30C higher. Elevated temperature is a 
common secondary systemic insult to the injured 
brain and it is a prognostic factor of the patient 
outcome. There are invasive, as well as non-invasive, 
continuous cerebral temperature monitoring devices 
for measuring the brain temperature. However, 
brain temperature monitoring is not widely used 
during neurocritical care of patients with severe TBI 
due to limited availability and high cost of these 
devices.4,28  
 
CONTINOUS EVOKED POTENTIAL MONITORING 
Another promising monitoring modality is 
continuous evoked potential monitoring, which has 
the unique ability to detect any reduction in 
neuronal activity in association with declines in CPP. 
Though new equipment allows it application at the 
bedside, it has the major disadvantage of forcing 
wave morphology into analyzable data. Current most 
studies analyze rather the relationship with outcome 
than describing patterns guiding therapy and 
management.17  
 
BIOCHEMICAL MARKERS 
A variety of serum biochemical markers for brain 
dysfunction have been investigated and used, 
although interest in some of these such as CK-BB and 
LDH 1 has been short lived. On the other hand there 
are many promising results from clinical studies in 
particular as far as the GFAP, the MBP and the S-
100Β protein concern. It is obvious that the 
literature regarding the S-100Β protein is quite more 
extensive. On the other hand minimal literature is 
available for FABP, tau proteins, Hsp70s, RANTES, 
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and other serum inflammatory factors and their role 
as serum markers of brain damage. The assessment 
of the primary brain injury and the detection of 
ongoing secondary brain damage during intensive 
care period seem to be the most promising clinical 
applications. However, further clinical and 
experimental studies have to be performed in order 
to identify new more reliable serum brain 
biochemical markers, clarify their precise release 
mechanisms from damaged cells (glial cells or 
neurons) through the brain blood barrier and 
validate their clinical utility.43, 44, 45 
A prominent role in prevention and prognosis of 
secondary brain damages is played by the 
scientifically as well as highly trained nursing stuff of 
the emergency department and intensive care unit. 
Their main purpose is the systematic monitoring and 
accurate recording of all the parameters that will 
determine the path of the condition of the patient. 
In the event of variation of the above mentioned 
parameters, the nursing stuff, have to inform the 
physician and then follow each protocol applicable 
to the respective cases. 
 
PROGNOSTIC FACTORS FOR PATIENTS WITH 
SECONDARY BRAIN DAMAGE 
The outcome of patients with severe head injury can 
be defined crudely in terms of death and survival. 
Late studies have shown that the mortality rate in 
severe head injury (GCS<9) has decreased from 50% 
to approximately 30-40%. However, the quality of 
survival is a most important issue. For this reason, 
the Glasgow Outcome Scale is a scale that has been 
invented in order to describe the overall social 
capability or dependence of the individual. It 
constitutes of five main categories: 
1. Death. 
2. Vegetative state (absence of awareness). 
3. Severely disable (conscious but disabled and 
dependent). 
4. Moderately disabled (disabled but independent). 
 5. Good recovery (resumption of normal life). 
Categories 3-5 can be subdivided into further 
degrees of disability. 
The Glasgow Outcome Scale is a practical scale to 
assess disability, which can be applied with 
consistency by a wide range of clinicians. Used in 
conjunction with the Glasgow Coma Scale, the 
Glasgow Outcome Scale forms the basis for the 
comparison and cost-benefit analysis of different 
regiments of treatment. 
Though the evidence base for the treatment of 
patients with secondary brain damage is extremely 
limited, there are some documented factors that 
influence the outcome and therefore they are 
considered prognostic factors. The main factors are 
the nature and the extent of intracranial and 
extracranial damage, the depth and the duration of 
post-traumatic coma, the patient’s age, the genes, 
the general medical health and previous state of 
function, the quality of available clinical care and the 
access to rehabilitation centers.  
Social-environmental factors, as socioeconomic 
status, social support, caregiver and family 
functioning also can influence outcomes after TBI. 
Access to rehabilitation services can be negatively 
impacted by a lack of specialty providers, particularly 
in rural areas, as well as a lack of financial resources 
available to a person with TBI. The availability and 
level of insurance coverage are especially important. 
Early imaging reduces time to detection of life-
threatening complications and is also associated 
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with better outcomes. Also, advances in 
understanding the pathophysiology, monitoring, and 
imaging of brain injury have allowed the 
development of evidence-based intensive care 
management strategies and there is good evidence 
that this improves outcome. In addition it is 
documented that early nutritional support is 
associated with better outcomes. In patients with 
severe TBI, adequate nutrition that is started early 
after injury is associated with enhanced immunity, 
decreased infectious morbidity, shortened length of 
hospitalization, improved neurological recovery and 
reduced mortality.  
In literature only a few predictive models for patient 
outcomes after severe TBI have been proposed. A 
relatively simple prognostic model using 7 predictive 
baseline characteristics including age, motor score, 
pupillary reactivity, hypoxia, hypotension, computed 
tomography classification, and traumatic 
subarachnoid hemorrhage has been reported to 
accurately predict 6-month outcome in patients with 
severe or moderate TBI. A predictive model based 
on age, absence of light reflex, presence of extensive 
subarachnoid hemorrhage, ICP, and midline shift 
was shown to have high predictive value and to be 
useful for decision making, review of treatment, and 
family counseling in case of TBI.7, 17, 20, 27, 30, 35-36, 38-41 
 
CONCLUSIONS 
Traumatic Brain Injury is a serious public health 
problem all over the world. Each year, traumatic 
brain injuries contribute to a substantial number of 
deaths and cases of permanent disability. Most 
probably patients with severe TBI will have 
secondary brain damage and will need to be nursed 
in the ICU. Diagnosis needs to be realized early in 
order to prevent every possible complication and 
deterioration of the patient’s status and to offer the 
appropriate management. Management of TBI in 
intensive care is very difficult and it is becoming 
more difficult when the complications and organ 
dysfunctions are added. There are many factors that 
influence the patient’s outcome and many of these 
are related to the management in the ICU. Therefore 
when special protocols for the patient treatment are 
followed in conjunction with the proper support 
therapy and close management, the mortality and 
morbidity of TBI patients can be decreased and 
patients can be offered an ameliorated quality of life 
after the injury. 
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